SciELO - Scientific Electronic Library Online

 
vol.36 issue5Rare brown tumor location in chronic renal failureBK virus nephropathy in a renal transplant patient: Potential role of electron microscopy in diagnosis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

My SciELO

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nefrología (Madrid)

On-line version ISSN 1989-2284Print version ISSN 0211-6995

Nefrología (Madr.) vol.36 n.5 Cantabria Sep./Oct. 2016

https://dx.doi.org/10.1016/j.nefro.2016.03.016 

Letters to the Editor

When kidneys are no longer a friend: An “out of the box” management for an unexpected evolution of an uncommon disease

Cuando los riñones dejan de ser un amigo: Una gestión “fuera de la caja” de una evolución imprevista de una enfermedad poco común

Sandra Silvaa  *  , Ricardo Pereirab  , Ivo Cunhab  , Carlos Ferreirac  , Ana Brancoa  , Eduardo Eirasb  , Mrinalini Honavard  , Joana Simõesb  , Teresa Santosa  , Teresa Chuvaa  , José Costaa 

aNephrology, Hospital Pedro Hispano, Porto, Portugal

bInternal Medicine, Hospital Pedro Hispano, Porto, Portugal

cUrology, Hospital Pedro Hispano, Porto, Portugal

dPathology, Hospital Pedro Hispano, Porto, Portugal

Dear Editor,

AA amyloidosis (AAA) is one of most severe complications of chronic inflammatory and infectious diseases and may induce nephrotic syndrome.1 Its association with Crohn's disease has been regularly reported, but amyloidosis complicating ulcerative colitis (UC) has been described only exceptionally.2

We report a case of a 58-year-old woman who was admitted with anasarca and nephrotic syndrome (NS). Relevant medical history included UC, gangrenous pyoderma and a tuberculous empyema. In 2002, a NS was identified and a renal biopsy displayed the diagnosis of AAA. In addition to treatment with 5-aminosalicylic-acid, a trial of colchicine was implemented but had to be stopped due to diarrhea. Renal function (RF) was sustainably preserved and the proteinuria spontaneously remitted. Throughout time she had long-lasting, moderate gastrointestinal symptoms with evidence of mild endoscopic inflammation. In 2015 she developed once more disabling proteinuria with normal RF and a diagnostic workup corroborated the clinical impression of recurrence of her amyloidosis (Table 1). An endoscopic review exhibited mild disease and, in addition to messalazine and prednisone, she was started on azathioprine, which had to be suspended due to pancreatitis. Therapy with an angiotensin-converting enzyme inhibitor was initiated but not tolerated; albumin-plus-furosemide infusion led merely to temporary improvement. A decision to deteriorate RF to decrease proteinuria was attempted: indomethacin led to acute renal dysfunction but didn’t significantly improved proteinuria. Hemodialysis was started but had to be interrupted due to hemodynamic instability. After a multidisciplinary consultation, she underwent a bilateral nephrectomy. Post-operatively, serum albumin and postural symptoms gradually improved with subsequent better hemodialysis tolerance. Histology revealed extensive amyloid deposits (Fig. 1) and immunohistochemical staining was positive for AA amyloid. Nutritional and functional status gradually improved.

Table 1 Laboratory tests results. 

Result Reference range
Hemoglobin (g/dL) 9.7 12-16
Leukocytes (103/μL) 9.3 4-11
Platelets (103/μL) 183 150-400
C-reactive protein (mg/L/sedimentation rate 1st h) 24/127 <5/0-30
Total protein/albumin (g/dL) 4.4/1.2 6.4-8.3/3.5-5.0
AST/ALT/LDH (U/L)a 11/18/205 5-34/<55/110-220
Fasting glucose/total bilirubin (mg/dL) 83/0.7 60-110/0.2-1.2
Total/LDL/HDL cholesterol (mg/dL) 270/169/40 <200/<100/≥60
Urea/creatinine (mg/dL) 52/0.7 21-43/0.6-1.1
Urinalysis/24 hours protein (mg/day) 4+ proteinuria/19538 0+/<300
Serum immunoelectrophoresis/serum kappa-lambda ratio Absence of monoclonal gammopathy/normal
Urinary electrophoresis/urinary immunoelectrophoresis Albumin = 46% and gamma globulin = 14%/no band suggestive of monoclonality
Tests for hepatitis B and C, HIVb, and syphilis Negative
ANA, anti-dsDNA and ANCAc antibodies; C3 and C4 complement levels Normal
Serum amyloide A (mg/L) 79.4 <7

aAST: aspartate transaminase, ALT: alanine transaminase, LDH: lactate dehydrogenase.

bHIV: human immunodeficiency virus.

cANA: antinuclear antibodies, anti-dsDNA: anti-double stranded DNA antibodies, ANCA: antineutrophil cytoplasmic antibodies.

Fig. 1 Histological examination of the kidneys. (A) Glomerular nodular deposits of amyloid stained with Congo red. (B) Amyloid showing typical apple-green birefringence under polarized light. 

AAA in the setting of UC is a rarity and typically, severe gastrointestinal illness precedes the development of amyloidosis,3 however this was not the case in our patient, who had a long standing, though mild disease. We speculate that the ongoing activity and the prolonged duration may have had a role; nevertheless, an additional contribution from the tuberculosis cannot be ruled out.

Another peculiar aspect is the spontaneous remission of the patient's NS. Improvement of amyloidosis manifestations is extensively documented in the context of remission of the underlying disease, but spontaneous regression is extremely unlikely.4

Patients with large proteinuria due to AAA can experience a life-threatening cachexic state with massive edema, respiratory distress and infectious complications, along with a poor functional status and a reduced quality-of-life. Up to the present, AAA has no specific treatment and despite the development of novel therapies (eprodisate)5 targeting the formation/stability of fibrils, the current available approach is to treat the underlying condition and thereby reduce the amyloid production. Nevertheless, this goal is not always achieved and the management of proteinuria can be challenging, resorting, in intractable cases like ours, to renal ablation. Medical ablation, with non-steroidal anti-inflammatory drugs6 has been attempted; bilateral renal artery embolization is an alternative, although frequently complicated by a ‘post-infarction syndrome’.7 Recently, bilateral ureteral ligation8 has been described, but the experience is limited and can induce persistent loin pain and ascending infections. Surgical nephrectomy is another option: although laparoscopic surgery is a less invasive procedure than an open nephrectomy, it precludes the chance for peritoneal dialysis and, consequently, we elected a bilateral nephrectomy by lombotomy.

The histological examination of the kidneys revealed extensive presence of AA amyloid deposits comprising the glomeruli, the blood vessels and the interstitium, an infrequent finding in the review by Hopfer et al.,9 who reported interstitium involvement in only 5.9%.

AAA has a major impact in patient's quality of life: Esteve et al.10 reported that in 1/3 of the patients, dialysis was not performed due to their poor clinical condition and disturbing quality of life. Bilateral nephrectomy in our patient, led to an improvement in hemodynamic stability allowing hemodialysis to be accomplished. Additionally, her functional and nutritional status enhanced gradually.

Radical bilateral nephrectomy may be considered in seriously ill patients with nephrotic syndrome and disabling complications of proteinuria.

Bibliografía

1. Khalighi M, Wallace D, Palma-Diaz M. Amyloid nephropathy. Clin Kidney J. 2014;7:97-106. [ Links ]

2. Serra I, Oller B, Mañosa M, Naves JE, Zabana Y, Cabré E, et al. Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome. J Crohns Colitis. 2010;4:269-74. [ Links ]

3. Cabezuelo JB, Egea JP, Ramos F, Torrella E, Muray S, Alcázar C. Utilidad del infliximab en el tratamiento de la amiloidosis secundaria en la enfermedad de Crohn. Nefrologia. 2012;32:385-8. [ Links ]

4. Costero O, Riñón C, Gil F, Díaz C, Hevia C, Picazo ML, et al. Recurrence and spontaneous remission of nephrotic syndrome in secondary renal amyloidosis. Nefrologia. 2002;22:482-5. [ Links ]

5. Dember LM, Hawkins PN, Hazenberg BPC, Gorevic PD, Merlini G, Butrimiene I, et al. Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med. 2007;356:2349-60. [ Links ]

6. Olivero JJ, Frommer JP, Gonzalez JM. Medical nephrectomy: the last resort for intractable complications of the nephrotic syndrome. Am J Kidney Dis. 1993;21:260-3. [ Links ]

7. Keller FS, Coyle M, Rosch J, Dotter CT. Percutaneous renal ablation in patients with end-stage renal disease: alternative to surgical nephrectomy. Radiology. 1986;159:447-51. [ Links ]

8. Keddis MT, Stegall MD, Textor SC. Renal ablation using bilateral ureteral ligation for nephrotic syndrome due to renal amyloidosis. Clin Kidney J. 2012;5:153-4. [ Links ]

9. Hopfer H, Wiech T, Mihatsch MJ. Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type. Nephrol Dial Transplant. 2011;26:2877-84. [ Links ]

10. Esteve V, Almirall J, Ponz E, García N, Ribera L, Larrosa M, et al. Afectación renal en la amiloidosis. Características clínicas, evolución y supervivencia. Nefrologia. 2006;26:212-7. [ Links ]

Corresponding author. E-mail address: oliveirasilva.sandra@gmail.com (S. Silva).

Conflicts of interest

The authors declare that they have no conflict of interest.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License